Insight Molecular Diagnostics Inc. (IMDX)

NASDAQ: IMDX · Real-Time Price · USD

6.01

+0.34 (6.00%)

At close: Feb 27, 2026, 4:00 PM EST

6.00

-0.01 (-0.12%)

After-hours: Feb 27, 2026, 4:10 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Research and Development of Diagnostic Tests for The Detection of Cancer	1.88M	1.50M	958.00K	2.20M	1.22M
Research and Development of Diagnostic Tests for The Detection of Cancer Growth	25.15%	56.89%	-56.41%	80.76%	-
Total	1.88M	1.50M	958.00K	2.20M	1.22M
Total Growth	25.15%	56.89%	-56.41%	80.76%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	1.67M	916.83K	737.66K	1.00M	741.76K
United States Growth	82.60%	24.29%	-26.57%	35.42%	-
Outside of The United States	206.91K	586.17K	220.34K	1.24M	474.24K
Outside of The United States Growth	-64.70%	166.03%	-82.18%	160.70%	-
Total	1.88M	1.50M	958.00K	2.24M	1.22M
Total Growth	25.15%	56.89%	-57.25%	84.28%	-

Source: S&P Global Market Intelligence.